Navigation Links
Natural Alternatives International, Inc. Announces Fiscal 2009 Q4 and Full Year Results
Date:9/22/2009

ions in the fourth quarter of fiscal 2009 was $1.2 million or $0.17 per diluted share as compared to a net loss of $3,000 or $0.00 per share in the fourth quarter of fiscal 2008. The increase in net income from continuing operations was attributable to an improved product sales mix, reduced labor and other manufacturing costs and lower selling, general and administrative expenses associated with our cost reduction and organizational consolidation efforts during fiscal 2009. During the second half of fiscal 2009, our cost reduction program resulted in operating expense savings of approximately $3.0 million compared to our cost structure in the comparable prior year period. We expect our cost reduction program to further reduce our operating overhead costs in fiscal 2010 by approximately $3.5 million as compared to fiscal 2009.

The net loss from discontinued operations of $115,000 or $0.02 per diluted share in the fourth quarter of fiscal 2009 compared to a net loss of $165,000 or $0.02 per diluted share in the fourth quarter of fiscal 2008. Overall, net income for the fourth quarter was $1.1 million or $0.16 per diluted share as compared to a net loss of $168,000 or $0.02 per diluted share in the comparable quarter last year.

On July 31, 2009, we sold substantially all of the remaining assets of our wholly owned subsidiary, Real Health Laboratories, Inc. (RHL), related to its wholesale and direct-to-consumer business to PharmaCare US Inc. and PharmaCare Laboratories Pty Ltd. for a cash purchase price of $500,000. As additional compensation, RHL may receive up to an additional $500,000 from the buyers as a conditional earn-out if the RHL business acquired by the buyers meets or exceeds certain budgeted profitability criteria during the period August 1, 2009 through July 31, 2010. The company anticipates the remaining wind-down business activity of RHL will terminate during the second half of fiscal 2010.

As
'/>"/>

SOURCE Natural Alternatives International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Head Lice Meet Their Natural Match - Leading Experts Say Safe Solution Proves Best for Lice and Nit Removal
2. Traditional Chinese Medicine and Acupuncture Continue to Grow in Popularity Due to Focus on Natural Health
3. Filmmaker John Hughes' Recent Untimely Death is a Call for Better Understanding of Sudden Cardiac Death, the Leading Cause of Natural Death in the U.S.
4. Protica Teams With UNFI/Select Nutrition to distribute All-Natural Protein Shot, Proasis
5. Nuvilex, Inc. Announces Reme-Flu(TM) as Trade Name for All-Natural Flu Remedy Formula
6. Rest Easy, the Safe, All-Natural Bed Bug Travel Spray
7. Jarrow Formulas, Inc. to Unveil Children's Natural Health Products at Upcoming Natural Products Expo East Show in Boston
8. Nuvilex, Inc. Finalizes Joint Venture Agreement for the Development of Broad Spectrum All-Natural Flu Remedies
9. XanGo Introduces a New Dietary Supplement That Restores Youthful Vigor - Naturally
10. Lose Weight, Lower Cholesterol, and Stay Healthy at School: Natural Solutions Magazine Shows You How
11. New Online Health Encyclopedia NaturalPedia.com Distills Knowledge From Industrys Top Authors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Food and Health Bureau has invited expressions of interest ... private hospitals at four sites in the Hong Kong ... March 31, 2010. ,, At a press conference, ... said the promotion of private hospital development was one ... Hong Kong government policy announced by Chief Executive Donald ...
(Date:12/15/2009)... Dec. 15 Our Lady of Lourdes Health ... Jersey hospitals, has agreed to pay the United States ... Medicare, the Justice Department announced today. The two hospitals ... Camden, N.J., and Lourdes Medical Center of Burlington County ... defendant in a suit brought by a whistleblower, Tony ...
(Date:12/15/2009)... would have really been in trouble, expert says , , ... the pandemic H1N1 swine flu has revealed serious flaws ... emergencies, a new report says. , The report, prepared ... Wood Johnson Foundation, also finds the dire economy has ... 2009 H1N1 outbreak is the latest in a series ...
(Date:12/15/2009)... will train advocates to be leaders in the ... with support from experts in online learning, the ... Dec. 15 ONE and ... applications for the first-ever "Malaria Griots" program, a ... participants to become leaders in the fight against ...
(Date:12/15/2009)... Patient advocate Betsy McCaughey, Ph.D., ... that, "it doesn,t matter whether there,s a public option. ... public option - give government authority over how your ... new social agenda by shifting billions of dollars from ... immigrants, and local politicians." ,, Betsy McCaughey ...
Breaking Medicine News(10 mins):Health News:Hong Kong Government Invites Expressions of Interest in Development of Private Hospitals 2Health News:Parent Company of Two New Jersey Hospitals to Pay U.S. $7.95 Million to Settle False Claims Act Allegations 2Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 2Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 4
... in Tripura due to naturally present arsenic, fuelling fears ... Health Engineering (PHE) department chief engineer Sunil Kumar Bhowmik ... that underground water contains arsenic of not less that ... for the tests were collected from Hrishyamukh and Santir ...
... genes to be produced from a single gene. By ... of proteins from a finite number of genes. A ... and the Howard Hughes Medical Institute, shows how the ... way that alternative splicing is controlled in the brain. ...
... who consume one portion of salmon per week are protected ... 43 percent, a study from Sweden has revealed. , ... Cancer has indicated the benefits of consuming omega-3 fatty acids ... cancer. Additionally, Fish is known to positively impact mood and ...
... indication of diabetes. Researchers from Harvard School of Public Health ... kill people much before they are even diagnosed with the ... nations. Their findings have shown that high blood sugar is ... results show that one in five deaths from heart disease ...
... According to a recent study, mice die early when exposed ... proposes working unusual // shifts and flying across time zones ... that older humans shorten their lives by flying across time ... might be a potential problems,' said study co-author Gene Block, ...
... H5N1 bird flu in its Fujian province as reported by a science ... Lin Friday refuted the report in the US Proceedings of the National ... its Fujian province had already spread to Malaysia, the Laos and Thailand, ... ,'In fact, there is no such thing as a new Fujian ...
Other Medicine News:Health News:Alternative Splicing - Molecular Cloning 2Health News:Alternative Splicing - Molecular Cloning 3Health News:Alternative Splicing - Molecular Cloning 4Health News:Jet Lag May Cause Health Problems: Study 2
(Date:12/15/2009)... -- Robbins & Myers, Inc. (NYSE: RBN ... its fiscal 2010 first quarter ending November 30, 2009, ... A live webcast is scheduled for ... Peter C. Wallace, President and Chief Executive Officer, ... Officer, will be discussing the Company,s performance and responding ...
(Date:12/15/2009)... LOUIS, Dec. 15 KV Pharmaceutical ... 2009, the Company received a written notice (the "Notice") ... 7/23/99, a stockholder of the Company, requesting that the ... a record date for stockholder action by written consent ... fill a vacant director seat resulting from Ronald J. ...
(Date:12/15/2009)... Dec. 15 SRI International, an independent ... award of U.S. patent 7,592,021 for a new ... of drugs through the human body,s mucous membranes. ... and allows for a much longer release time ... ,, Transmucosal delivery is an effective means to ...
Breaking Medicine Technology:KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 2KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 3KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 4KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 5KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 6KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 7SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 2SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 3SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 4SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 5Recently Approved Onglyza Is Covered by 44 Percent of Commercial Health Plans But Less Than One Percent of Medicare Plans for The Treatment of Type 2 14449 1Recently Approved Onglyza Is Covered by 44 Percent of Commercial Health Plans But Less Than One Percent of Medicare Plans for The Treatment of Type 2 14449 2Resverlogix Appoints A Brad Cann as Chief Financial Officer 14444 1Resverlogix Appoints A Brad Cann as Chief Financial Officer 14444 2Resverlogix Appoints A Brad Cann as Chief Financial Officer 14444 3MicroRNA Biomarkers Provide Reliable Diagnosis from Blood Samples 5428 1MicroRNA Biomarkers Provide Reliable Diagnosis from Blood Samples 5428 2
... 2007 - Abraxis BioScience,Inc. (NASDAQ:ABBI), an integrated, ... studies that,support the role of SPARC (secreted ... cancer and Abraxis' nanoparticle,albumin-bound (nab(TM)) tumor-targeting technology ... (AACR) Annual Meeting held,April 14-18, 2007 in ...
... Md., April 19, 2007 /PRNewswire-FirstCall/--,EntreMed, Inc. , ... treatment of cancer and inflammatory diseases,today announced ... novel cell cycle inhibitor. The data were ... for Cancer Research (AACR),Annual Meeting being held ...
Other Medicine Technology:Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 2Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 3Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 4Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 5EntreMed Presents Preclinical Data for MKC-1 in Hematological,Cancers 2EntreMed Presents Preclinical Data for MKC-1 in Hematological,Cancers 3EntreMed Presents Preclinical Data for MKC-1 in Hematological,Cancers 4
... INC. (CBI) Prolactin ELISA kit is used ... human serum or plasma. Human prolactin (lactogenic ... with a molecular weight of approximately 23,000 ... a solid phase direct sandwich ELISA method. ...
... Prolactin ELISA Kit is enzyme immunoassay ... Human Prolactin (PRL) concentration in serum. ... quantitative determination of many protein hormones ... accurate, sensitive, reproducible, rapid and specific ...
... This Enzyme-Linked Immunosorbent Assay (ELISA) serves the ... from plasma, serum and,urine. In a 1 ... samples is bound to an,available excess of ... to the surface of the microtitre plates. ...
... The AxSYM BNP assay allows you ... the status of your heart due ... versus NT-ProBNP. The AxSYM BNP assay ... simple, walk-away resultson a platform that ...
Medicine Products: